Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bridging Community Gaps Photovoice (BCGP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03291717
Recruitment Status : Active, not recruiting
First Posted : September 25, 2017
Last Update Posted : September 3, 2019
Sponsor:
Collaborators:
Mental Health Center of Denver
Connecticut State, Department of Mental Health and Addiction Services
Riverside Community Care
Information provided by (Responsible Party):
Erna Sally Rogers, Boston University Charles River Campus

Brief Summary:
The purpose of this study is to test a peer-led intervention intended to promote the community living and participation of individuals with psychiatric disabilities entitled "Bridging Community Gaps Photovoice" (BCGP). The intervention targets increasing community involvement of individuals with psychiatric disabilities through reduction in self-stigma and perceived stigma, enhancing opportunities for community participation, and support to achieve community participation goals.

Condition or disease Intervention/treatment Phase
Mental Illness Social Isolation Behavioral: Bridging Community Gaps Photovoice (BCGP) Not Applicable

Detailed Description:
The BCGP intervention is 6 months long and the investigators expect that participants will experience lower self and perceived stigma, increased community participation and sense of belonging, and improved psychosocial functioning and personal growth after the intervention. The intervention is comprised of a 12-week class that meets once a week for two hours, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The purpose of the individual support is to reinforce the class activities and to ensure the participants meets their community participation goal. The proposed study is a randomized trial which will be conducted at Boston University Center for Psychiatric Rehabilitation (BUCPR) in Massachusetts, the Mental Health Center of Denver (MHCD) in Colorado, and the Greater Bridgeport Mental Health Center (GBMHC) in Connecticut.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 197 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Randomized Trial of a Peer-led Intervention to Promote Community Living and Participation - The Bridging Community Gaps Photovoice
Actual Study Start Date : September 5, 2017
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : August 2020

Arm Intervention/treatment
Experimental: Bridging Community Gaps Photovoice (BCGP)
The BCGP program is a 6-month photovoice-based intervention to help individuals with psychiatric disabilities enhance their community participation.
Behavioral: Bridging Community Gaps Photovoice (BCGP)
Participants assigned to this group will be part of the 6-month long BCGP intervention, which involves a 12- week class that meets weekly, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The BCGP classes follow a manualized curriculum with sessions that combine didactic information, Photovoice exercises, and group discussions to empower participants in pursuing community participation goals, all refined with input from individuals with a lived experience.

No Intervention: Services as Usual
Individuals in this group continue with their regular mental health services with no additional intervention.



Primary Outcome Measures :
  1. UCLA Loneliness Scale [ Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months ]
    is a 20-item 4-point Likert-type scale, widely used measure of loneliness and social isolation. Cronbach's alpha coefficients ranging from .89 to .94.

  2. Multi-Dimensional Assessment of Community Participation [ Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months ]
    Consists of a set of objective and subjective measures of community belonging, inclusion and participation.


Secondary Outcome Measures :
  1. Internalized Stigma of Mental Illness Scale [ Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months ]
    29-item, 4-point scale from (strongly disagree to strongly agree) assesses behaviors, thoughts and feelings that are self-stigmatizing including alienation, stereotype endorsement, social withdrawal, stigma resistance.

  2. The Stigma Scale [ Time Frame: Change from Baseline to 3 months, 3 months to 6 months, 6 months to 9 months, 9 months to 12 months ]
    28 item, 5 point scale (strongly disagree to strongly agree) measuring experienced and anticipated stigma.

  3. Approaches to Coping with Anti-Stigma [ Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months ]
    27-item instrument with a 4 point scale (strongly disagree to strongly agree) measuring strategies to cope with stigma: secrecy, withdrawal, educating, challenging, and distancing.

  4. Personal Growth and Recovery Scale [ Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months ]
    25-item, 4 point scale (strongly disagree to strongly agree) of items measuring psychosocial functioning and recovery.

  5. Community Goal Achievement Scale [ Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months ]
    adapted from Goal Attainment Scale, provides a structured approach to determining goal achievement regardless of the type or uniqueness of goal .

  6. Behavior and Symptom Identification Scale (BASIS - R) [ Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months ]
    A 24-item scale that measures: mood disturbances, anxiety, interpersonal and role functioning, daily living skills, psychotic symptoms, impulsivity and substance use



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. are 18 or older.
  2. are recipients of services at research sites due to having a DSM-V diagnosis of mental illness, including dual diagnosis (dual diagnosis refers to co-occurring mental illness and alcohol/ substance use disorder).
  3. are interested in enhancing their community participation.
  4. are not currently receiving individual peer support services.
  5. are able to read and write in English.

Exclusion Criteria:

1)Inability to give full and knowing consent.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03291717


Locations
Layout table for location information
United States, Colorado
Mental Health Center of Denver
Denver, Colorado, United States, 80204
United States, Connecticut
Greater Bridgeport Mental Health Center
Bridgeport, Connecticut, United States, 06610
United States, Massachusetts
Boston University, Center for Psychiatric Rehabilitation
Boston, Massachusetts, United States, 02215
Horizon House- Riverside Community Care
Wakefield, Massachusetts, United States, 01880
Sponsors and Collaborators
Boston University Charles River Campus
Mental Health Center of Denver
Connecticut State, Department of Mental Health and Addiction Services
Riverside Community Care
Investigators
Layout table for investigator information
Principal Investigator: Erna S Rogers, PhD Boston University

Layout table for additonal information
Responsible Party: Erna Sally Rogers, Research Professor, Boston University Charles River Campus
ClinicalTrials.gov Identifier: NCT03291717    
Other Study ID Numbers: 4591
First Posted: September 25, 2017    Key Record Dates
Last Update Posted: September 3, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Erna Sally Rogers, Boston University Charles River Campus:
Mental Illness
Community Participation
Stigma
Photovoice
Additional relevant MeSH terms:
Layout table for MeSH terms
Mental Disorders